EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Sourdough Bread with Different Fermentation Times: A Randomized Clinical Trial in Subjects with Metabolic Syndrome

Karla Alejandra Pérez-Vega iD, Albert Sanllorente, María-Dolores Zomeño iD, Ana Quindós, Júlia Muñoz-Martínez iD, Mireia Malcampo, Ana Aldea-Perona, Álvaro Hernáez, Aleix Lluansí iD, Marc Llirós iD, Isidre Elias, Núria Elias-Masiques und 11 weitere

Nutrients · 2024

DOI: 10.3390/nu16152380 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Karla Alejandra Pérez-Vega und 22 weiteren Autor:innen. Beteiligte Einrichtung: Hospital del Mar Research Institute, 08003 Barcelona, Spain. Hauptthemen laut MEDLINE: Bread, Metabolic Syndrome, Fermentation, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Ministry of Economy, Industry and Competitiveness (MINECO) RETOS program, Agència de Gestió d'Ajuts Universitaris i de Recerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Mediterranean diet, featuring sourdough bread, shows promise in managing metabolic syndrome. This study explored the effects of two sourdough breads, with differing fermentation times but similar nutritional profiles, on inflammation, satiety, and gut microbiota composition in adults with metabolic syndrome. In a double-blind clinical trial, participants were randomized to consume either Elias Boulanger® long-fermentation (48 h) sourdough bread (EBLong) or Elias Boulanger® short-fermentation (2 h) sourdough bread (EBShort) over a two-month period. We assessed clinical parameters, inflammatory biomarkers, satiety-related hormones, and the richness and abundance of gut microbiota at baseline and follow-up. The participants included 31 individuals (mean age, 67, 51.6% female). EBShort was associated with reduced levels of soluble intercellular adhesion molecule (sICAM), and all participants, regardless of the intervention, exhibited a decrease in sICAM and diastolic pressure from baseline (p < 0.017). At follow-up, plasminogen activator inhibitor-1 (PAI-1) levels were lower in EBShort (−744 pg/mL; 95%CI: −282 to −1210 pg/mL) compared to EBLong. No differences in microbiota richness or abundance were observed. EBShort bread was effective in reducing some inflammation markers. The consumption of sourdough bread may offer potential benefits in reducing inflammation markers in individuals with metabolic syndrome; however, longer fermentation times did not show additional benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BreadMetabolic SyndromeFermentationGastrointestinal MicrobiomeDiet, MediterraneanHumansFemaleMaleDouble-Blind MethodMiddle AgedAgedBiomarkersPlasminogen Activator Inhibitor 1Time FactorsIntercellular Adhesion Molecule-1Inflammation

Stichwörter der Autor:innen

PAI-1blood pressuremetabolic syndromesICAMsourdough bread

Substanzen

BiomarkersPlasminogen Activator Inhibitor 1Intercellular Adhesion Molecule-1

Autor:innen und Institutionen

  • Hospital del Mar Research Institute, 08003 Barcelona, Spain.
  • Consorcio Centro de Investigación Biomédica En Red (CIBER), M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • PhD Program in Food Science and Nutrition, Universitat de Barcelona, 08028 Barcelona, Spain.
  • Unitat de Suport a la Recerca Metropolitana Sud, Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08907 Hospitalet de Llobregat, Spain.
  • Direcció d'Atenció Primària Metropolitana Sud, Institut Català de la Salut, 08907 Hospitalet de Llobregat, Spain.
  • Blanquerna School of Health Sciences, Universitat Ramon Llull, 08025 Barcelona, Spain.

ORCID-Profile: Karla Alejandra Pérez-Vega, María-Dolores Zomeño, Júlia Muñoz-Martínez, Aleix Lluansí, Marc Llirós, Javier Hernando-Redondo

Förderung

  • Instituto de Salud Carlos III
  • Ministry of Economy, Industry and Competitiveness (MINECO) RETOS program
  • Agència de Gestió d'Ajuts Universitaris i de Recerca
  • the European Union; Ministry of Economy, Industry and Competitiveness (MINECO) RETOS program
  • Agència de Gestió d’Ajuts Universitaris i de Recerca

Zitieren

APA

Pérez-Vega, K. A., Sanllorente, A., Zomeño, M. D., Quindós, A., Muñoz-Martínez, J., Malcampo, M., Aldea-Perona, A., Hernáez, Á., Lluansí, A., Llirós, M., Elias, I., Elias-Masiques, N., Aldeguer, X., Muñoz, D., Gaixas, S., Blanchart, G., Schröder, H., Hernando-Redondo, J., Carrón, N., …, & Castañer, O. (2024). Sourdough Bread with Different Fermentation Times: A Randomized Clinical Trial in Subjects with Metabolic Syndrome. Nutrients. https://doi.org/10.3390/nu16152380

Vancouver

Pérez-Vega KA, Sanllorente A, Zomeño MD, Quindós A, Muñoz-Martínez J, Malcampo M, et al. Sourdough Bread with Different Fermentation Times: A Randomized Clinical Trial in Subjects with Metabolic Syndrome. Nutrients. 2024. doi:10.3390/nu16152380

BibTeX
@article{PrezVega2024,
  author = {Pérez-Vega, Karla Alejandra and Sanllorente, Albert and Zomeño, María-Dolores and Quindós, Ana and Muñoz-Martínez, Júlia and Malcampo, Mireia and Aldea-Perona, Ana and Hernáez, Álvaro and Lluansí, Aleix and Llirós, Marc and Elias, Isidre and Elias-Masiques, Núria and Aldeguer, Xavier and Muñoz, Daniel and Gaixas, Sònia and Blanchart, Gemma and Schröder, Helmut and Hernando-Redondo, Javier and Carrón, Nerea and González-Torres, Pedro and Konstantinidou, Valentini and Fitó, Montserrat and Castañer, Olga},
  title = {Sourdough Bread with Different Fermentation Times: A Randomized Clinical Trial in Subjects with Metabolic Syndrome},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16152380}
}
Kostenlos starten →